Bibliography

Found 14 results

Filters: Author is Steven D. Douglas [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

D

Lai JP, Cnaan A, Zhao H, Douglas SD. Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions. Journal of Neuroscience Methods [Internet]. 2008 ;168:127-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18035424

E

Douglas SD, Cnaan A, Lynch KG, Benton T, Zhao H, Gettes DR, Evans DL. Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. AIDS Research and Human Retroviruses [Internet]. 2008 ;24:375-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18327973

Spitsin S, Stevens K, Douglas SD. Expression of substance P, Neurokinin-1 receptor and immune markers in the brains of individuals with HIV-1 associated neuropathology. Journal of the Neurological Sciences [Internet]. 2013 ;334(1-2):18-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23916293

N

Tuluc F, Lai JP, Kilpatrick LE, Evans DL, Douglas SD. Neurokinin 1 receptor isoforms and the control of innate immunity. Trends in Immunology [Internet]. 2009 ;30:271-276. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19427266

Wang X, Douglas SD, Song L, Wang Y, Ho WZ. Neurokinin-1 Receptor Antagonist (Aprepitant) Suppresses HIV-1 Infection of Microglia/Macrophages. Journal of Neuroimmune Pharmacology [Internet]. 2008 . Available from: http://www.ncbi.nlm.nih.gov/pubmed/18654860

Douglas SD, Lai JP, Tuluc F, Schwartz L, Kilpatrick LE. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis. Annals of the New York Academy of Sciences [Internet]. 2008 ;1144:90-96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19076368

Douglas SD, Leeman SE. Neurokinin-1 Receptor: Functional Significance in the Immune System in Reference to Selected Infections and Inflammation. Annals of the New York Academy of Sciences [Internet]. 2011 ;1217:83-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21091716

Douglas SD, Lynch KG, Lai JP. Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals. Journal of the Neurological Sciences [Internet]. 2008 ;272:174-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18572194

Vinet-Oliphant H, Alvarez X, Buza E, Borda J, Mohan M, Aye P, Tuluc F, Douglas SD, Lackner AA. Neurokinin-1 Receptor (NK1-R) Expression in the Brains of SIV-Infected Rhesus Macaques: Implications for Substance P in NK1-R Immune Cell Trafficking into the CNS. The American Journal of Pathology [Internet]. 2010 ;177:1286-1297. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20671267

Douglas SD. Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy. In: NIMH HIV Preclinical/Clinical Therapeutics Research Meeting. NIMH HIV Preclinical/Clinical Therapeutics Research Meeting. ; 2006.

Douglas SD. Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy. 2003 .

P

Joseph J, Clifford DB, Douglas SD, Fox HS, Gendelman HE, Gonzalez-Scarano F, Grant I, Major E, McArthur JC. Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008. Journal of NeuroImmune Pharmacology [Internet]. 2009 ;4(3):283-297. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19455426

S

Monaco-Shawver L, Schwartz L, Tuluc F, Guo CJ, Lai JP, Gunnam SM, Kilpatrick LE, Banerjee PP, Douglas SD, Orange JS. Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor. Journal of Leukocyte Biology [Internet]. 2011 ;89:113-125. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20940324

T

Douglas SD. Tachykinins, Mononuclear Phagocytes and HIV-1 Infection. 2002 .